1,2-dimethylhydrazine increases expression ISO RGD:735524 6480464 1, 2-Dimethylhydrazine results in increased expression of HSPB8 mRNA CTD PMID:22206623 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of HSPB8 mRNA CTD PMID:22841810 17beta-estradiol multiple interactions ISO RGD:1346187 6480464 [Estradiol co-treated with EGF protein] results in increased expression of HSPB8 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol increases expression ISO RGD:1346187 6480464 Estradiol results in increased expression of HSPB8 mRNA CTD PMID:19619570 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of HSPB8 mRNA CTD PMID:26496021 1H-pyrazole increases expression ISO RGD:735524 6480464 pyrazole results in increased expression of HSPB8 mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1346187 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HSPB8 mRNA more ... CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPB8 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HSPB8 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1346187 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPB8 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735524 6480464 Tetrachlorodibenzodioxin affects the expression of HSPB8 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346187 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPB8 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735524 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPB8 mRNA CTD PMID:19770486 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1346187 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of HSPB8 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1346187 6480464 Lactic Acid results in decreased expression of HSPB8 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane affects expression ISO RGD:735524 6480464 4, 4'-diaminodiphenylmethane affects the expression of HSPB8 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:735524 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HSPB8 mRNA CTD PMID:30951980 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of HSPB8 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1346187 6480464 Fenretinide results in increased expression of HSPB8 mRNA CTD PMID:16671099 5-aza-2'-deoxycytidine affects expression ISO RGD:1346187 6480464 Decitabine affects the expression of HSPB8 mRNA CTD PMID:23300844 5-fluorouracil increases expression ISO RGD:1346187 6480464 Fluorouracil results in increased expression of HSPB8 mRNA CTD PMID:16557594 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of HSPB8 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:1346187 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of HSPB8 mRNA] CTD PMID:21233418 afimoxifene decreases response to substance ISO RGD:1346187 6480464 HSPB8 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1346187 6480464 Aflatoxin B1 affects the expression of HSPB8 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1346187 6480464 Aflatoxin B1 results in increased expression of HSPB8 mRNA CTD PMID:22100608 , PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of HSPB8 mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression ISO RGD:735524 6480464 Tretinoin results in increased expression of HSPB8 mRNA CTD PMID:20117194 alpha,alpha-trehalose increases expression ISO RGD:735524 6480464 Trehalose results in increased expression of HSPB8 mRNA CTD PMID:30335591 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HSPB8 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of HSPB8 mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:735524 6480464 pyrazolanthrone promotes the reaction [Ozone results in increased expression of HSPB8 mRNA] CTD PMID:17460151 antimonite multiple interactions ISO RGD:1346187 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA CTD PMID:32076005 antimycin A increases expression ISO RGD:1346187 6480464 Antimycin A results in increased expression of HSPB8 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO RGD:1346187 6480464 Antirheumatic Agents results in increased expression of HSPB8 mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1346187 6480464 aristolochic acid I results in increased expression of HSPB8 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1346187 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSPB8 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1346187 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSPB8 mRNA CTD PMID:32525701 arsenous acid increases expression ISO RGD:1346187 6480464 Arsenic Trioxide results in increased expression of HSPB8 mRNA CTD PMID:26705709 astemizole increases expression EXP 6480464 Astemizole results in increased expression of HSPB8 mRNA CTD PMID:20221588 benzo[a]pyrene multiple interactions ISO RGD:735524 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to HSPB8 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression ISO RGD:735524 6480464 Benzo(a)pyrene results in increased expression of HSPB8 mRNA CTD PMID:21569818 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1346187 6480464 Benzo(a)pyrene results in increased expression of HSPB8 mRNA CTD PMID:20106945 more ... beta-naphthoflavone increases expression ISO RGD:1346187 6480464 beta-Naphthoflavone results in increased expression of HSPB8 mRNA CTD PMID:19737606 bis(2-ethylhexyl) phthalate increases expression ISO RGD:735524 6480464 Diethylhexyl Phthalate results in increased expression of HSPB8 mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1346187 6480464 Diethylhexyl Phthalate results in increased expression of HSPB8 mRNA CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of HSPB8 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1346187 6480464 bisphenol A results in decreased expression of HSPB8 mRNA CTD PMID:33670352 bisphenol A increases expression ISO RGD:735524 6480464 bisphenol A results in increased expression of HSPB8 mRNA CTD PMID:30951980 , PMID:33221593 bisphenol A increases expression ISO RGD:1346187 6480464 bisphenol A results in increased expression of HSPB8 mRNA CTD PMID:23524099 , PMID:27685785 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HSPB8 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol F increases expression ISO RGD:735524 6480464 bisphenol F results in increased expression of HSPB8 mRNA CTD PMID:30951980 Butylparaben increases expression ISO RGD:1346187 6480464 butylparaben results in increased expression of HSPB8 mRNA CTD PMID:23524099 cadmium atom increases expression ISO RGD:1346187 6480464 Cadmium results in increased expression of HSPB8 mRNA CTD PMID:21120746 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of HSPB8 mRNA CTD PMID:22110744 calcitriol multiple interactions ISO RGD:1346187 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of HSPB8 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1346187 6480464 Calcitriol results in increased expression of HSPB8 mRNA CTD PMID:21592394 , PMID:26485663 carbamazepine affects expression ISO RGD:1346187 6480464 Carbamazepine affects the expression of HSPB8 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:735524 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1346187 6480464 CGP 52608 promotes the reaction [RORA protein binds to HSPB8 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:1346187 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPB8 mRNA CTD PMID:32152650 chloroethene decreases expression ISO RGD:735524 6480464 Vinyl Chloride results in decreased expression of HSPB8 mRNA CTD PMID:18579281 chlorpyrifos increases expression ISO RGD:735524 6480464 Chlorpyrifos results in increased expression of HSPB8 mRNA CTD PMID:32715474 cisplatin affects expression ISO RGD:1346187 6480464 Cisplatin affects the expression of HSPB8 mRNA CTD PMID:23300844 clofibrate multiple interactions ISO RGD:735524 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of HSPB8 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSPB8 mRNA] CTD PMID:17585979 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of HSPB8 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1346187 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPB8 mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO RGD:1346187 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPB8 mRNA more ... CTD PMID:20971185 more ... copper(II) sulfate increases expression ISO RGD:1346187 6480464 Copper Sulfate results in increased expression of HSPB8 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1346187 6480464 Asbestos, Crocidolite results in increased expression of HSPB8 mRNA CTD PMID:18687144 , PMID:25351596 CU-O LINKAGE increases expression ISO RGD:1346187 6480464 cupric oxide results in increased expression of HSPB8 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of HSPB8 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1346187 6480464 Cyclosporine results in increased expression of HSPB8 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO RGD:1346187 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPB8 mRNA CTD PMID:32152650 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA, [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA CTD PMID:29038839 deoxycholic acid multiple interactions ISO RGD:1346187 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPB8 mRNA CTD PMID:32152650 diarsenic trioxide increases expression ISO RGD:1346187 6480464 Arsenic Trioxide results in increased expression of HSPB8 mRNA CTD PMID:26705709 diclofenac increases expression ISO RGD:735524 6480464 Diclofenac results in increased expression of HSPB8 mRNA CTD PMID:26934552 dioxygen multiple interactions ISO RGD:735524 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPB8 mRNA CTD PMID:30529165 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1346187 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA CTD PMID:32076005 disulfiram multiple interactions ISO RGD:1346187 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPB8 mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of HSPB8 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1346187 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1346187 6480464 Doxorubicin results in decreased expression of HSPB8 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of HSPB8 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:1346187 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPB8 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1346187 6480464 entinostat results in increased expression of HSPB8 mRNA CTD PMID:26272509 , PMID:27188386 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of HSPB8 mRNA CTD PMID:29038839 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA, [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA CTD PMID:29038839 fenofibrate multiple interactions ISO RGD:735524 6480464 [PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of HSPB8 mRNA CTD PMID:21318169 fenofibrate increases expression ISO RGD:735524 6480464 Fenofibrate results in increased expression of HSPB8 mRNA CTD PMID:21318169 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of HSPB8 mRNA CTD PMID:20924750 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HSPB8 mRNA CTD PMID:24136188 furan increases methylation EXP 6480464 furan results in increased methylation of HSPB8 gene CTD PMID:22079235 genistein increases expression ISO RGD:1346187 6480464 Genistein results in increased expression of HSPB8 mRNA CTD PMID:23524099 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HSPB8 mRNA CTD PMID:33387578 glycochenodeoxycholic acid multiple interactions ISO RGD:1346187 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPB8 mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:1346187 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPB8 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:1346187 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPB8 mRNA CTD PMID:32152650 hydrazine increases expression ISO RGD:735524 6480464 hydrazine results in increased expression of HSPB8 mRNA CTD PMID:15282401 hydrogen peroxide increases expression ISO RGD:735524 6480464 Hydrogen Peroxide results in increased expression of HSPB8 mRNA CTD PMID:14729362 lactulose increases expression ISO RGD:735524 6480464 Lactulose results in increased expression of HSPB8 mRNA CTD PMID:30335591 Licochalcone B increases expression ISO RGD:1346187 6480464 licochalcone B results in increased expression of HSPB8 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RGD:735524 6480464 Lipopolysaccharides results in increased expression of HSPB8 mRNA CTD PMID:15919760 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of HSPB8 mRNA] CTD PMID:16415329 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of HSPB8 mRNA CTD PMID:16415329 LY294002 decreases expression ISO RGD:1346187 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of HSPB8 protein CTD PMID:21233418 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of HSPB8 mRNA CTD PMID:28801915 melibiose increases expression ISO RGD:735524 6480464 Melibiose results in increased expression of HSPB8 mRNA CTD PMID:30335591 mercury dibromide multiple interactions ISO RGD:1346187 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPB8 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of HSPB8 mRNA CTD PMID:16507785 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of HSPB8 mRNA CTD PMID:19564919 methamphetamine multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of HSPB8 mRNA] CTD PMID:19564919 methotrexate increases expression ISO RGD:1346187 6480464 Methotrexate results in increased expression of HSPB8 mRNA CTD PMID:17379860 methylisothiazolinone increases expression ISO RGD:1346187 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of HSPB8 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1346187 6480464 methylmercuric chloride results in increased expression of HSPB8 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO RGD:735524 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of HSPB8 protein CTD PMID:26558463 N-methylformamide affects expression ISO RGD:735524 6480464 methylformamide affects the expression of HSPB8 mRNA, methylformamide analog affects the expression of HSPB8 mRNA CTD PMID:17040096 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of HSPB8 mRNA] CTD PMID:16415329 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of HSPB8 mRNA CTD PMID:24136188 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of HSPB8 mRNA CTD PMID:22110744 nickel sulfate increases expression ISO RGD:1346187 6480464 nickel sulfate results in increased expression of HSPB8 mRNA CTD PMID:22714537 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of HSPB8 mRNA CTD PMID:24136188 organoselenium compound multiple interactions ISO RGD:1346187 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of HSPB8 mRNA CTD PMID:25167922 ozone multiple interactions ISO RGD:735524 6480464 pyrazolanthrone promotes the reaction [Ozone results in increased expression of HSPB8 mRNA] CTD PMID:17460151 paracetamol multiple interactions ISO RGD:735524 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of HSPB8 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSPB8 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:1346187 6480464 Acetaminophen results in decreased expression of HSPB8 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HSPB8 mRNA CTD PMID:17202762 more ... paracetamol affects expression ISO RGD:735524 6480464 Acetaminophen affects the expression of HSPB8 mRNA CTD PMID:17562736 pentachlorophenol increases expression ISO RGD:735524 6480464 Pentachlorophenol results in increased expression of HSPB8 mRNA CTD PMID:23892564 pentanal increases expression ISO RGD:1346187 6480464 pentanal results in increased expression of HSPB8 mRNA CTD PMID:26079696 phenobarbital affects expression ISO RGD:735524 6480464 Phenobarbital affects the expression of HSPB8 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1346187 6480464 Phenylmercuric Acetate results in increased expression of HSPB8 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1346187 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPB8 mRNA CTD PMID:27188386 phlorizin decreases expression ISO RGD:735524 6480464 Phlorhizin results in decreased expression of HSPB8 mRNA CTD PMID:22538082 phorone affects expression EXP 6480464 phorone affects the expression of HSPB8 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO RGD:735524 6480464 pirinixic acid results in increased expression of HSPB8 mRNA CTD PMID:18445702 potassium dichromate increases expression ISO RGD:735524 6480464 Potassium Dichromate results in increased expression of HSPB8 mRNA CTD PMID:23608068 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of HSPB8 mRNA CTD PMID:29038839 prochloraz multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA CTD PMID:29038839 progesterone increases expression EXP 6480464 Progesterone results in increased expression of HSPB8 mRNA CTD PMID:20726854 progesterone multiple interactions ISO RGD:1346187 6480464 [Estradiol co-treated with Progesterone] results in increased expression of HSPB8 mRNA CTD PMID:20660070 propanal increases expression ISO RGD:1346187 6480464 propionaldehyde results in increased expression of HSPB8 mRNA CTD PMID:26079696 rac-lactic acid decreases expression ISO RGD:1346187 6480464 Lactic Acid results in decreased expression of HSPB8 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1346187 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of HSPB8 mRNA, Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of HSPB8 mRNA] CTD PMID:19059307 , PMID:21185374 ranitidine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of HSPB8 mRNA] CTD PMID:16415329 resveratrol increases expression ISO RGD:735524 6480464 resveratrol results in increased expression of HSPB8 protein CTD PMID:25505154 rotenone increases expression ISO RGD:735524 6480464 Rotenone results in increased expression of HSPB8 mRNA CTD PMID:23186747 rotenone increases expression ISO RGD:1346187 6480464 Rotenone results in increased expression of HSPB8 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1346187 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of HSPB8 mRNA] CTD PMID:19564919 silicon dioxide increases expression ISO RGD:1346187 6480464 Silicon Dioxide analog results in increased expression of HSPB8 mRNA, Silicon Dioxide results in increased expression of HSPB8 mRNA CTD PMID:25351596 , PMID:25895662 silver atom increases expression ISO RGD:1346187 6480464 Silver results in increased expression of HSPB8 mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression ISO RGD:1346187 6480464 Silver results in increased expression of HSPB8 mRNA CTD PMID:26014281 , PMID:28959546 sirolimus decreases expression ISO RGD:1346187 6480464 Sirolimus results in decreased expression of HSPB8 protein CTD PMID:21233418 sodium arsenate decreases expression ISO RGD:735524 6480464 sodium arsenate results in decreased expression of HSPB8 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:1346187 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSPB8 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:735524 6480464 sodium arsenite results in increased expression of HSPB8 mRNA CTD PMID:16014739 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of HSPB8 mRNA CTD PMID:25993096 sodium dodecyl sulfate increases expression ISO RGD:1346187 6480464 Sodium Dodecyl Sulfate results in increased expression of HSPB8 mRNA CTD PMID:31734321 sodium fluoride increases expression ISO RGD:735524 6480464 Sodium Fluoride results in increased expression of HSPB8 mRNA CTD PMID:21340527 , PMID:27862939 Soman increases expression EXP 6480464 Soman results in increased expression of HSPB8 mRNA CTD PMID:19281266 tamoxifen multiple interactions ISO RGD:1346187 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of HSPB8 mRNA CTD PMID:19059307 tamoxifen affects expression ISO RGD:735524 6480464 Tamoxifen affects the expression of HSPB8 mRNA CTD PMID:20937368 tert-butyl hydroperoxide increases expression ISO RGD:735524 6480464 tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA CTD PMID:14729362 testosterone multiple interactions ISO RGD:1346187 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of HSPB8 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1346187 6480464 Testosterone results in increased expression of HSPB8 mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HSPB8 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:735524 6480464 Carbon Tetrachloride results in increased expression of HSPB8 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HSPB8 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:735524 6480464 titanium dioxide results in decreased expression of HSPB8 mRNA CTD PMID:23557971 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of HSPB8 mRNA CTD PMID:21683754 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HSPB8 mRNA CTD PMID:33387578 troglitazone increases expression ISO RGD:735524 6480464 troglitazone results in increased expression of HSPB8 mRNA CTD PMID:28973697 tunicamycin increases expression ISO RGD:1346187 6480464 Tunicamycin results in increased expression of HSPB8 mRNA CTD PMID:29453283 urethane decreases expression ISO RGD:1346187 6480464 Urethane results in decreased expression of HSPB8 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of HSPB8 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:1346187 6480464 Valproic Acid results in decreased expression of HSPB8 mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:1346187 6480464 Valproic Acid results in increased expression of HSPB8 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1346187 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPB8 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1346187 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPB8 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1346187 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPB8 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:1346187 6480464 zoledronic acid results in increased expression of HSPB8 mRNA CTD PMID:24714768
